On October 17, the UCLA Department of Neurosurgery announced that it had receive a $2 million donation to establish an endowed chair in epilepsy research. Thomas and Nadia Davies made the donation in memory of their late daughter Alfonsina (Nina) Q. Davies and in honor of Dr. Paul Crandall, the UCLA neurosurgeon who ended her epileptic seizures. The Davies family invested more than a decade in seeking ways to stop the uncontrollable seizures that had tormented their daughter since birth. The neurologists they met offered only temporary solutions. When the Davieses arrived at UCLA in 1977, they consulted with De. Crandall who was the founder of UCLA’s first epilepsy surgery research program. He had been developing experimental treatments since the early 1960s and is now retired and a professor emeritus of neurosurgery at the David Geffen School of Medicine at UCLA.
Dr. Crandall suggested an experimental surgery to control Nina’s intractable epilepsy. At the time, few surgical programs for epilepsy existed in the U.S., and doctors were often reluctant to consider a surgical approach to treating the disease. “Dr. Crandall’s scientific knowledge and surgical skills saved our daughter’s life,” Nadia said. “We are eternally grateful for his lifelong study of surgical interventions to prevent epileptic seizures.” After her surgery, Nina completed college and realized her dream of becoming a teacher. She went on to earn a doctoral degree in education, eventually becoming assistant superintendent for the Santa Ana Unified School District. She helped many students with disabilities, both social and physical, relating firsthand to the difficulties they faced. Sadly, in 2011, Nina died at 52 from what is known as sudden unexplained death in epilepsy (SUDEP), a rare outcome for those who suffer from the disease.
The Davieses have established the Alfonsina Q. Davies Endowed Chair in Honor of Paul Crandall, M.D., for Epilepsy Research to recognize Crandall’s early research, which helped Nina and contributed to UCLA’s reputation as a world leader in the surgical treatment of epilepsy.
The UCLA Department of Neurosurgery is committed to providing the most comprehensive patient care through innovative clinical programs in minimally invasive brain and spinal surgery; neuroendoscopy; neuro-oncology for both adult and pediatric brain tumors; cerebrovascular surgery; stereotactic radiosurgery for brain and spinal disorders; surgery for movement disorders such as Parkinson’s disease; and epilepsy surgery. For 20 consecutive years, the department has been ranked among the top 10 neurosurgery programs in the nation by U.S. News & World Report.
$111,000 donation for research on severe childhood neurological disease
Neuroscience breakthrough: New hope for paraplegics
UCLA neural stem cell research might benefit patients with stroke and autism
UCLA pediatric cancer researchers to receive funds from kid’s group